If they ran the company based on homophobic beliefs like yours, your shares would soon have the same value as your ideas. And, I'm pretty sure you would not like that that very much! You invest in J&J because it returns divs and capital appreciation. Why not consider the possibility that they know what they're doing, even if you do not!
If Apple are not paying for the service to Siri users then Nuance should simply shut down the servers Apple to poling. Business is business and Apple has none of the attributes of a charity! There seems to be a serious management problem at Nuance.
If management were separated from the company, the sum of the parts would be worth more than the parts individually. All that's needed here is some simple subtraction to get the valuation corrected.
That takes me back to my original question:- Why has none of the considerable cash flow over the last few years wound up on the balance sheet?
Well then, given that revenues are on the decline, should we assume the cash generated and directed toward 'expansionary' programs was wasted or is there another possibly positive way to look at the situation?
Well unfortunately that $850 million is simply borrowed money so it would be inaccurate to call it cash from operations. it belongs to the lenders that Yandex borrowed it from.
This brings us back to my original question. Of the considerable cashflow from the business can anyone explain where it all went. Why is none of it on the balance sheet? Is this a financial management issue or a business model issue. As a comparison, take a look at QIWI. there we see strong financial management and accumulated cash from operations on the balance sheet.
Use your head and ask yourself why Merck might want to continue such an arrangement. That's what rational investors are supposed to do. That's what your head is for!
I'm green and it only took 15 years and 23 average down events.
Let's not consider opportunity cost for a while! The amount of capital gains tax AGEN helped me avoid over thos 15 years is also considerable. Key, if i don't get to keep the money, why should Uncle Sam?
I think she could be sued for that article. Amarin is seeking to share the results of a successful phase 3 trial on a marketed product with doctors. The artcile does not mention what Amarin is suing for. The article is a distortion of the case, to the point where the facts the facts are turned on their head.
Don't worry.If anyone looks at the actual financials, they'll see that the balance sheet puts the value of COCP at under 1c per share. Everything else is pure speculation based on the hope that Dr. Frost will bring forth a miracle that could be commercialized in 10 or 12 years time. You should be able to double-down at half today's price and then again at half that price and indeed, you may be able to continue doing this all the way to fair value!
That's the question. Tons of cash on the balance sheet, no debt, strong growth, low multiples and healthy cash flow makes QIWI seem very attractive. One has to wonder what the CITI analysts are thinking. I suspect the depth of their analysis is not enough to understand QIWI and YNDX are very different animals and thus the downgrade.